SEARCH

SEARCH BY CITATION

References

  • Adlard PA, Cotman CW (2004). Voluntary exercise protects against stress-induced decreases in brain-derived neurotrophic factor protein expression. Neuroscience 124: 985992.
  • Ago Y, Arikawa S, Yata M, Yano K, Abe M, Takuma K et al. (2008). Antidepressant-like effects of the glucocorticoid receptor antagonist RU-43044 are associated with changes in prefrontal dopamine in mouse models of depression. Neuropharmacology 55: 13551363.
  • Anacker C, Zunszain PA, Cattaneo A, Carvalho LA, Garabedian MJ, Thuret S et al. (2011). Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor. Mol Psychiatry 16: 738750.
  • Arunrut T, Alejandre H, Chen M, Cha J, Russo-Neustadt A (2009). Differential behavioral and neurochemical effects of exercise, reboxetine and citalopram with the forced swim test. Life Sci 84: 584589.
  • Aziz NA, Pijl H, Frolich M, van der Graaf AW, Roelfsema F, Roos RA (2009). Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease. J Clin Endocrinol Metab 94: 12231228.
  • Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M, Moore K et al. (2000). Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med 62: 633638.
  • Bhagwagar Z, Rabiner EA, Sargent PA, Grasby PM, Cowen PJ (2004). Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry 9: 386392.
  • Bill DJ, Knight M, Forster EA, Fletcher A (1991). Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia. Br J Pharmacol 103: 18571864.
  • Bjorkqvist M, Petersen A, Bacos K, Isaacs J, Norlen P, Gil J et al. (2006). Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. Hum Mol Genet 15: 17131721.
  • Bjornebekk A, Mathe AA, Gruber SH, Brene S (2008). Housing conditions modulate escitalopram effects on antidepressive-like behaviour and brain neurochemistry. Int J Neuropsychopharmacol 11: 11351147.
  • Bjornebekk A, Mathe AA, Brene S (2010). The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression. Hippocampus 20: 820828.
  • Brummett BH, Boyle SH, Siegler IC, Kuhn CM, Ashley-Koch A, Jonassaint CR et al. (2008). Effects of environmental stress and gender on associations among symptoms of depression and the serotonin transporter gene linked polymorphic region (5-HTTLPR). Behav Genet 38: 3443.
  • Bymaster FP, Zhang W, Carter PA, Shaw J, Chernet E, Phebus L et al. (2002). Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex. Psychopharmacology (Berl) 160: 353361.
  • Cheng Y, Peng Q, Hou Z, Aggarwal M, Zhang J, Mori S et al. (2011). Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model. Neuroimage 56: 10271034.
  • Chopra KK, Ravindran A, Kennedy SH, Mackenzie B, Matthews S, Anisman H et al. (2009). Sex differences in hormonal responses to a social stressor in chronic major depression. Psychoneuroendocrinology 34: 12351241.
  • Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R et al. (2009). Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373: 746758.
  • Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R et al. (2010). Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev 4: CD006117.
  • Clark PJ, Kohman RA, Miller DS, Bhattacharya TK, Brzezinska WJ, Rhodes JS (2011). Genetic influences on exercise-induced adult hippocampal neurogenesis across 12 divergent mouse strains. Genes Brain Behav 10: 345353.
  • Cryan JF, Markou A, Lucki I (2002). Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23: 238245.
  • David DJ, Samuels BA, Rainer Q, Wang JW, Marsteller D, Mendez I et al. (2009). Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 62: 479493.
  • Dawson LA, Nguyen HQ, Smith DL, Schechter LE (2002). Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex. J Psychopharmacol 16: 145152.
  • van Dellen A, Cordery PM, Spires TL, Blakemore C, Hannan AJ (2008). Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease. BMC Neurosci 9: 34.
  • Deslandes A, Moraes H, Ferreira C, Veiga H, Silveira H, Mouta R et al. (2009). Exercise and mental health: many reasons to move. Neuropsychobiology 59: 191198.
  • Drevets WC, Thase ME, Moses-Kolko EL, Price J, Frank E, Kupfer DJ et al. (2007). Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol 34: 865877.
  • Droste SK, Gesing A, Ulbricht S, Muller MB, Linthorst AC, Reul JM (2003). Effects of long-term voluntary exercise on the mouse hypothalamic-pituitary-adrenocortical axis. Endocrinology 144: 30123023.
  • Duan W, Peng Q, Masuda N, Ford E, Tryggestad E, Ladenheim B et al. (2008). Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease. Neurobiol Dis 30: 312322.
  • Dubreucq S, Marsicano G, Chaouloff F (2010). Emotional consequences of wheel running in mice: which is the appropriate control? Hippocampus [Epub ahead of print].
  • Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Stout JC (2007). Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study. Biol Psychiatry 62: 13411346.
  • Duman CH, Schlesinger L, Russell DS, Duman RS (2008). Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Res 1199: 148158.
  • Dunn AL, Trivedi MH, Kampert JB, Clark CG, Chambliss HO (2005). Exercise treatment for depression: efficacy and dose response. Am J Prev Med 28: 18.
  • El Yacoubi M, Bouali S, Popa D, Naudon L, Leroux-Nicollet I, Hamon M et al. (2003). Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proc Natl Acad Sci USA 100: 62276232.
  • Fava M, Kendler KS (2000). Major depressive disorder. Neuron 28: 335341.
  • Fediuc S, Campbell JE, Riddell MC (2006). Effect of voluntary wheel running on circadian corticosterone release and on HPA axis responsiveness to restraint stress in Sprague-Dawley rats. J Appl Physiol 100: 18671875.
  • Fox MA, Stein AR, French HT, Murphy DL (2010). Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT). Br J Pharmacol 159: 879887.
  • Froger N, Palazzo E, Boni C, Hanoun N, Saurini F, Joubert C et al. (2004). Neurochemical and behavioral alterations in glucocorticoid receptor-impaired transgenic mice after chronic mild stress. J Neurosci 24: 27872796.
  • Fuss J, Ben Abdallah NM, Vogt MA, Touma C, Pacifici PG, Palme R et al. (2010). Voluntary exercise induces anxiety-like behavior in adult C57BL/6J mice correlating with hippocampal neurogenesis. Hippocampus 20: 364376.
  • van Gaalen MM, Reul JH, Gesing A, Stenzel-Poore MP, Holsboer F, Steckler T (2002). Mice overexpressing CRH show reduced responsiveness in plasma corticosterone after a5-HT1A receptor challenge. Genes Brain Behav 1: 174177.
  • Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL (2008). The effectiveness of exercise interventions for people with Parkinson's disease: a systematic review and meta-analysis. Mov Disord 23: 631640.
  • Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ et al. (2005). Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry 10: 220224.
  • Greenwood BN, Foley TE, Day HE, Campisi J, Hammack SH, Campeau S et al. (2003). Freewheel running prevents learned helplessness/behavioral depression: role of dorsal raphe serotonergic neurons. J Neurosci 23: 28892898.
  • Grote HE, Bull ND, Howard ML, van Dellen A, Blakemore C, Barlett PF et al. (2005). Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine. Eur J Neurosci 22: 20812088.
  • Harkin A, Houlihan DD, Kelly JP (2002). Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramine. J Psychopharmacol 16: 115123.
  • Hedlund PB, Kelly L, Mazur C, Lovenberg T, Sutcliffe JG, Bonaventure P (2004). 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur J Pharmacol 487: 125132.
  • Hensler JG, Vogt MA, Gass P (2010). Regulation of cortical and hippocampal 5-HT(1A) receptor function by corticosterone in GR+/− mice. Psychoneuroendocrinology 35: 469474.
  • Hery M, Semont A, Fache MP, Faudon M, Hery F (2000). The effects of serotonin on glucocorticoid receptor binding in rat raphe nuclei and hippocampal cells in culture. J Neurochem 74: 406413.
  • Hoffmann P, Thoren P, Ely D (1987). Effect of voluntary exercise on open-field behavior and on aggression in the spontaneously hypertensive rat (SHR). Behav Neural Biol 47: 346355.
  • Holick KA, Lee DC, Hen R, Dulawa SC (2008). Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 33: 406417.
  • Ibi D, Takuma K, Koike H, Mizoguchi H, Tsuritani K, Kuwahara Y et al. (2008). Social isolation rearing-induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion-related behaviors in juvenile mice. J Neurochem 105: 921932.
  • Julien CL, Thompson JC, Wild S, Yardumian P, Snowden JS, Turner G et al. (2007). Psychiatric disorders in preclinical Huntington's disease. J Neurol Neurosurg Psychiatry 78: 939943.
  • Kishi T, Tsunoka T, Ikeda M, Kawashima K, Okochi T, Kitajima T et al. (2009). Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis. J Hum Genet 54: 629633.
  • Kohl Z, Kandasamy M, Winner B, Aigner R, Gross C, Couillard-Despres S et al. (2007). Physical activity fails to rescue hippocampal neurogenesis deficits in the R6/2 mouse model of Huntington's disease. Brain Res 1155: 2433.
  • Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI et al. (2000). Gender differences in chronic major and double depression. J Affect Disord 60: 111.
  • Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD et al. (2003). Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 23: 87888799.
  • Liu X, Peprah D, Gershenfeld HK (2003). Tail-suspension induced hyperthermia: a new measure of stress reactivity. J Psychiatr Res 37: 249259.
  • Lucassen PJ, Meerlo P, Naylor AS, van Dam AM, Dayer AG, Fuchs E et al. (2010). Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: implications for depression and antidepressant action. Eur Neuropsychopharmacol 20: 117.
  • Lukkes JL, Watt MJ, Lowry CA, Forster GL (2009). Consequences of post-weaning social isolation on anxiety behavior and related neural circuits in rodents. Front Behav Neurosci 3: 18.
  • Maj J, Moryl E (1992). Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations. J Neural Transm Gen Sect 88: 143156.
  • Malisch JL, Breuner CW, Kolb EM, Wada H, Hannon RM, Chappell MA et al. (2009). Behavioral despair and home-cage activity in mice with chronically elevated baseline corticosterone concentrations. Behav Genet 39: 192201.
  • Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C et al. (1996). Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87: 493506.
  • Marcus SM, Kerber KB, Rush AJ, Wisniewski SR, Nierenberg A, Balasubramani GK et al. (2008). Sex differences in depression symptoms in treatment-seeking adults: confirmatory analyses from the Sequenced Treatment Alternatives to Relieve Depression Study. Compr Psychiatry 49: 238246.
  • Marlatt MW, Lucassen PJ, van Praag H (2010). Comparison of neurogenic effects of fluoxetine, duloxetine and running in mice. Brain Res 1341: 9399.
  • Marshall J, White K, Weaver M, Flury Wetherill L, Hui S, Stout JC et al. (2007). Specific psychiatric manifestations among preclinical Huntington disease mutation carriers. Arch Neurol 64: 116121.
  • Mato S, Aso E, Castro E, Martin M, Valverde O, Maldonado R et al. (2007). CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors. J Neurochem 103: 21112120.
  • McKittrick CR, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR (1995). Serotonin receptor binding in a colony model of chronic social stress. Biol Psychiatry 37: 383393.
  • Meltzer HY, Maes M (1995). Effects of ipsapirone on plasma cortisol and body temperature in major depression. Biol Psychiatry 38: 450457.
  • Messa C, Colombo C, Moresco RM, Gobbo C, Galli L, Lucignani G et al. (2003). 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology (Berl) 167: 7278.
  • Miller JM, Brennan KG, Ogden TR, Oquendo MA, Sullivan GM, Mann JJ et al. (2009). Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality. Neuropsychopharmacology 34: 22752284.
  • Mintun MA, Sheline YI, Moerlein SM, Vlassenko AG, Huang Y, Snyder AZ (2004). Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography. Biol Psychiatry 55: 217224.
  • Mizuno T, Aoki M, Shimada Y, Inoue M, Nakaya K, Takahashi T et al. (2006). Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety. J Psychosom Res 60: 9197.
  • Mnie-Filali O, Lambas-Senas L, Zimmer L, Haddjeri N (2007). 5-HT7 receptor antagonists as a new class of antidepressants. Drug News Perspect 20: 613618.
  • Navines R, Gomez-Gil E, Martin-Santos R, de Osaba MJ, Escolar G, Gasto C (2007). Hormonal response to buspirone is not impaired in major depression. Hum Psychopharmacol 22: 389395.
  • Niven A, Rendell E, Chisholm L (2008). Effects of 72-h of exercise abstinence on affect and body dissatisfaction in healthy female regular exercisers. J Sports Sci 26: 12351242.
  • Overstreet DH (2002). Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists. Behav Genet 32: 335348.
  • Pang TY, Stam NC, Nithianantharajah J, Howard ML, Hannan AJ (2006). Differential effects of voluntary physical exercise on behavioral and brain-derived neurotrophic factor expression deficits in Huntington's disease transgenic mice. Neuroscience 141: 569584.
  • Pang TY, Du X, Zajac MS, Howard ML, Hannan AJ (2009). Altered serotonin receptor expression is associated with depression-related behavior in the R6/1 transgenic mouse model of Huntington's disease. Hum Mol Genet 18: 753766.
  • Paulsen JS, Nehl C, Hoth KF, Kanz JE, Benjamin M, Conybeare R et al. (2005). Depression and stages of Huntington's disease. J Neuropsychiatry Clin Neurosci 17: 496502.
  • Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross CA et al. (2008). The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model. Exp Neurol 210: 154163.
  • Petersen A, Wortwein G, Gruber SH, Mathe AA (2008). Escitalopram reduces increased hippocampal cytogenesis in a genetic rat depression model. Neurosci Lett 436: 305308.
  • Petit-Demouliere B, Chenu F, Bourin M (2005). Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 177: 245255.
  • Porsolt RD, Le Pichon M, Jalfre M (1977). Depression: a new animal model sensitive to antidepressant treatments. Nature 266: 730732.
  • Potter M, Yuan C, Ottenritter C, Mughal M, van Praag H (2010). Exercise is not beneficial and may accelerate symptom onset in a mouse model of Huntington's disease. PLoS Curr 2: RRN1201.
  • Pouladi MA, Graham RK, Karasinska JM, Xie Y, Santos RD, Petersen A et al. (2009). Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain 132: 919932.
  • Reith ME, Fischette CT (1991). Sertraline and cocaine-induced locomotion in mice. II. Chronic studies. Psychopharmacology (Berl) 103: 306313.
  • Renoir T, Paizanis E, Yacoubi ME, Saurini F, Hanoun N, Melfort M et al. (2008). Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice. Int J Neuropsychopharmacol 11: 11491162.
  • Richardson-Jones JW, Craige CP, Guiard BP, Stephen A, Metzger KL, Kung HF et al. (2010). 5-HT1A autoreceptor levels determine vulnerability to stress and response to antidepressants. Neuron 65: 4052.
  • Riedel WJ, Klaassen T, Griez E, Honig A, Menheere PP, van Praag HM (2002). Dissociable hormonal, cognitive and mood responses to neuroendocrine challenge: evidence for receptor-specific serotonergic dysregulation in depressed mood. Neuropsychopharmacology 26: 358367.
  • Rioux A, Fabre V, Lesch KP, Moessner R, Murphy DL, Lanfumey L et al. (1999). Adaptive changes of serotonin 5-HT2A receptors in mice lacking the serotonin transporter. Neurosci Lett 262: 113116.
  • Rossi DV, Burke TF, McCasland M, Hensler JG (2008). Serotonin-1A receptor function in the dorsal raphe nucleus following chronic administration of the selective serotonin reuptake inhibitor sertraline. J Neurochem 105: 10911099.
  • Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S et al. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301: 805809.
  • Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J et al. (2000). Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. Arch Gen Psychiatry 57: 174180.
  • Shapira B, Newman ME, Gelfin Y, Lerer B (2000). Blunted temperature and cortisol responses to ipsapirone in major depression: lack of enhancement by electroconvulsive therapy. Psychoneuroendocrinology 25: 421438.
  • Simpson JM, Gil-Mohapel J, Pouladi MA, Ghilan M, Xie Y, Hayden MR et al. (2011). Altered adult hippocampal neurogenesis in the YAC128 transgenic mouse model of Huntington disease. Neurobiol Dis 41: 249260.
  • Sjoberg RL, Nilsson KW, Nordquist N, Ohrvik J, Leppert J, Lindstrom L et al. (2006). Development of depression: sex and the interaction between environment and a promoter polymorphism of the serotonin transporter gene. Int J Neuropsychopharmacol 9: 443449.
  • Smith MA, Lyle MA (2006). Chronic exercise decreases sensitivity to mu opioids in female rats: correlation with exercise output. Pharmacol Biochem Behav 85: 1222.
  • Solberg LC, Horton TH, Turek FW (1999). Circadian rhythms and depression: effects of exercise in an animal model. Am J Physiol 276 (1 Pt 2): R152R161.
  • Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G (1998). Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 18: 73947401.
  • Strawbridge WJ, Deleger S, Roberts RE, Kaplan GA (2002). Physical activity reduces the risk of subsequent depression for older adults. Am J Epidemiol 156: 328334.
  • Sullivan GM, Ogden RT, Oquendo MA, Kumar JS, Simpson N, Huang YY et al. (2009). Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression. Biol Psychiatry 66: 223230.
  • Szewczyk B, Albert PR, Burns AM, Czesak M, Overholser JC, Jurjus GJ et al. (2009). Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder. Int J Neuropsychopharmacol 12: 155168.
  • The Huntington's Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72: 971983.
  • Trejo JL, Llorens-Martin MV, Torres-Aleman I (2008). The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis. Mol Cell Neurosci 37: 402411.
  • Yohrling IG, Jiang GC, DeJohn MM, Robertson DJ, Vrana KE, Cha JH (2002). Inhibition of tryptophan hydroxylase activity and decreased 5-HT1A receptor binding in a mouse model of Huntington's disease. J Neurochem 82: 14161423.
  • Zajac MS, Pang TY, Wong N, Weinrich B, Leang LS, Craig JM et al. (2010). Wheel running and environmental enrichment differentially modify exon-specific BDNF expression in the hippocampus of wild-type and pre-motor symptomatic male and female Huntington's disease mice. Hippocampus 20: 621636.